Twitter
LinkedIn
RSS
Facebook

Archive for the ‘FDA decisions’ Category


Health Canada Suspends Avastin’s Authorization




In the shadow of the U.S. FDA revoking its approval of Avastin for the treatment of metastatic breast cancer, the Canadian counterpart agency is following suit. According to the Toronto Sun: The agency said Avastin “has not been shown to be safe and effective” ………..Based on follow-up studies after Avastin was first authorized in Feb. […]

Read More...

The FDA Revokes Its Approval of Avastin For The Treatment of Metastatic Breast Cancer




Genentech is Reporting that: FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer South San Francisco, Calif. —  November 18, 2011 —  U.S. Food and Drug Administration (FDA) Commissioner revokes approval of Avastin for treatment of metastatic breast cancer (mBC) in the United States This action concludes the FDA’s review of Avastin’s use for mBC […]

Read More...